NIAGEN BIOSCIENCE, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $26.1M | $57.8M | $28.2M |
| FY2022 | $25.4M | $54.1M | $20.3M |
| FY2023 | $26.5M | $55.0M | $27.2M |
| FY2024 | $22.2M | $68.3M | $44.5M |
| FY2025 | $29.9M | $106.4M | $64.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $26.1M | $57.8M | $28.2M |
| FY2022 | $25.4M | $54.1M | $20.3M |
| FY2023 | $26.5M | $55.0M | $27.2M |
| FY2024 | $22.2M | $68.3M | $44.5M |
| FY2025 | $29.9M | $106.4M | $64.8M |